Can inflammatory biomarkers based on first trimester complete blood count parameters predict placental abruption ?: A case-control study

J Reprod Immunol. 2024 Aug:164:104279. doi: 10.1016/j.jri.2024.104279. Epub 2024 Jun 14.

Abstract

Objectives: Placental abruption (PA) is associated with adverse maternal and neonatal outcomes and has an etiological mechanism that is not yet fully understood. The prediction of PA, which has been the subject of numerous studies, remains a challenge. In particular, there is evidence that PA can be considered a chronic process. So, this study aimed to show inflammatory biomarkers based on complete blood count parameters may be used to predict PA.

Study design: A sample of 110 cases (pregnant women with PA) and 110 controls (healthy pregnant women with spontaneous labor) were required the study. The present case-control study included a total of 220 pregnant women. Inflammatory makers were used to evaluate the PA prediction RESULTS: Increases in body mass index, mean corpuscular volume and paletelet lymphocyte ratio are considered protective factors, while increases in neutrophil, the systemic inflammatory response index, neutrophil lymphocyte ratio and the pan-immune inflammation score are considered risk factors. Each 1 unit increase in neutrophil count increases the risk of a PA diagnosis by 1.81 times.

Conclusion: Recent studies indicate a strong heterogeneity of clinical courses leading to PA in premature and term births. In the present study, our results showed that, inflammation is associated with PA.

Keywords: Biomarkers; Neutrophil; Placental abruption; Systemic inflammatory response index.

MeSH terms

  • Abruptio Placentae* / blood
  • Abruptio Placentae* / diagnosis
  • Abruptio Placentae* / immunology
  • Adult
  • Biomarkers* / blood
  • Blood Cell Count
  • Case-Control Studies
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / diagnosis
  • Inflammation / immunology
  • Neutrophils / immunology
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Trimester, First* / blood
  • Pregnancy Trimester, First* / immunology
  • Prognosis
  • Risk Factors
  • Young Adult

Substances

  • Biomarkers